News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
675,334 Results
Type
Article (55494)
Company Profile (95)
Press Release (619730)
Multimedia
Podcasts (221)
Webinars (31)
Section
Business (206974)
Career Advice (2898)
Deals (33692)
Drug Delivery (225)
Drug Development (77458)
Employer Resources (182)
FDA (16007)
Job Trends (14953)
News (313150)
Policy (31071)
Tag
2025 Best Places to Work (14)
2026 Best Places to Work (18)
2027 BioCapital Standard (3)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (2929)
Academic (1)
Accelerated approval (75)
ADA (53)
Adcomms (43)
Allergies (219)
Alliances (44666)
ALS (284)
Alzheimer's disease (2063)
Antibody-drug conjugate (ADC) (737)
Approvals (16588)
Artificial intelligence (967)
ASCO (334)
Autoimmune disease (508)
Automation (75)
Bankruptcy (349)
Belgium (45)
Best Places to Work (11455)
BIO (75)
Biologics (112)
BIOSECURE Act (23)
Biosimilars (288)
BioSpace Insights (189)
Biotechnology (71)
Bispecific (60)
Bladder cancer (245)
Brain cancer (97)
Breast cancer (941)
Cancer (7714)
Cardiovascular disease (652)
Career advice (2490)
Career pathing (64)
CAR-T (446)
CDC (79)
CDMO (227)
Celiac Disease (5)
Cell-line development (1)
Cell therapy (1172)
Cervical cancer (65)
Clinical research (69412)
Collaboration (2658)
Commercialization (71)
Company closure (9)
Compensation (1855)
Complete response letters (124)
COVID-19 (2996)
CRISPR (142)
CRO (8)
C-suite (1706)
Cystic fibrosis (174)
Data (10773)
Decentralized trials (4)
Denatured (65)
Depression (221)
Dermatology (203)
Diabetes (801)
Diagnostics (7117)
Digital health (70)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (475)
Drug pricing (237)
Drug shortages (40)
Duchenne muscular dystrophy (375)
Earnings (69064)
Editorial (85)
Employer branding (24)
Employer resources (171)
ESMO (417)
Events (93595)
Executive appointments (1384)
Eye disease (23)
FDA (20862)
Fibrodysplasia Ossificans Progressiva (16)
Fragile X (5)
Friedreich's ataxia (28)
Frontotemporal dementia (40)
Funding (2226)
Gene editing (302)
Generative AI (88)
Gene therapy (933)
GLP-1 (1351)
Government (5087)
Grass and pollen (6)
Guidances (441)
Healthcare (19043)
Hematology (226)
HIV (126)
Huntington's disease (91)
Idiopathic pulmonary fibrosis (14)
IgA nephropathy (155)
Immunology and inflammation (406)
Immuno-oncology (157)
Indications (290)
Infectious disease (3433)
Inflammatory bowel disease (268)
Inflation Reduction Act (16)
Influenza (162)
Intellectual property (378)
Interviews (542)
IPO (16112)
IRA (57)
Job creations (3695)
Job search strategy (2029)
JPM (72)
Kidney cancer (31)
Kidney disease (172)
Labor market (128)
Layoffs (700)
Leadership (70)
Legal (6825)
Licensing (119)
Liver cancer (117)
Longevity (54)
Lung cancer (1072)
Lung diease (27)
Lymphoma (551)
Machine learning (73)
Management (68)
Manufacturing (1543)
Marketing (40)
MASH (255)
Medical affairs (5)
Medical device (13251)
Medtech (13538)
Mergers & acquisitions (19124)
Metabolic disorders (2075)
Middle East (2)
mRNA (329)
Multiple sclerosis (256)
Multispecific (6)
NASH (24)
Netherlands (36)
Neurodegenerative disease (608)
Neuropsychiatric disorders (147)
Neuroscience (4180)
Neurotech (3)
NextGen: Class of 2026 (6696)
Non-profit (4668)
Now hiring (87)
Obesity (988)
Opinion (401)
Ovarian cancer (291)
Pain (343)
Pancreatic cancer (442)
Parkinson's disease (466)
Partnered (45)
Patents (774)
Patient advocacy (7)
Patient recruitment (948)
Patient selection (113)
Peanut (73)
People (64137)
Peptides (42)
Pharmaceutical (27)
Pharmacy benefit managers (40)
Phase 1 (21252)
Phase 2 (30610)
Phase 3 (23501)
Pipeline (14168)
Policy (418)
Postmarket research (2285)
Preclinical (8878)
Press Release (71)
Prostate cancer (386)
Psychedelics (101)
Radioligand (1)
Radiopharmaceuticals (419)
Rare diseases (1557)
Real estate (5650)
Recruiting (79)
Regenerative medicine (34)
Regulatory (26489)
Reports (69)
Research institute (2606)
Resumes & cover letters (453)
Rett syndrome (59)
RNA editing (35)
RSV (102)
Saudi Arabia (1)
Schizophrenia (224)
Series A (386)
Series B (277)
Service/supplier (4)
Sickle cell disease (146)
Special edition (38)
Spinal muscular atrophy (190)
Sponsored (58)
Startups (3622)
State (2)
Stem cells (7)
Stomach cancer (23)
Substance use disorders (21)
Supply chain (159)
Switzerland (23)
Tariffs (101)
Tax incentives (2)
The Weekly (153)
Vaccines (1389)
Venture capital (180)
Weight loss (661)
Wet AMD (6)
Women's health (175)
Women in leadership (1)
Worklife (27)
Date
Today (196)
Last 7 days (853)
Last 30 days (3474)
Last 365 days (30442)
2026 (27485)
2025 (29327)
2024 (33874)
2023 (38253)
2022 (49241)
2021 (53427)
2020 (52498)
2019 (46197)
2018 (35166)
2017 (32159)
2016 (30709)
2015 (35291)
2014 (27778)
2013 (23476)
2012 (22750)
2011 (23428)
2010 (20390)
Location
Africa (937)
Alabama (113)
Alaska (7)
Arizona (352)
Arkansas (15)
Asia (41634)
Australia (7236)
California (15330)
Canada (4442)
China (1972)
Colorado (670)
Connecticut (704)
Delaware (503)
Europe (95824)
Florida (2411)
Georgia (501)
Hawaii (3)
Idaho (61)
Illinois (1283)
India (140)
Indiana (735)
Iowa (35)
Japan (747)
Kansas (147)
Kentucky (56)
Louisiana (60)
Maine (72)
Maryland (1794)
Massachusetts (10936)
Michigan (385)
Minnesota (797)
Mississippi (7)
Missouri (159)
Montana (35)
Nebraska (26)
Nevada (193)
New Hampshire (84)
New Jersey (4213)
New Mexico (33)
New York (4162)
North Carolina (1918)
North Dakota (14)
Northern California (7795)
Ohio (468)
Oklahoma (24)
Oregon (48)
Pennsylvania (2977)
Puerto Rico (38)
Rhode Island (60)
South America (1233)
South Carolina (100)
South Dakota (2)
Southern California (6276)
Tennessee (262)
Texas (2606)
United States (54454)
Utah (455)
Vermont (2)
Virginia (397)
Washington D.C. (79)
Washington State (1226)
West Virginia (4)
Wisconsin (178)
Wyoming (6)
675,334 Results for "pharmacyte biotech formerly known as nuvilex".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PharmaCyte Biotech Reports Strong Cash and Asset Position
November 13, 2026
·
2 min read
Press Releases
PharmaCyte Biotech, Inc. Announces Reverse Stock Split
November 11, 2026
·
3 min read
Deals
Stoffels strikes up new biotech in return to Galapagos cell therapy mission
A new biotech co-founded by Paul Stoffels has formed to take on the CAR T cell assets of Galapagos almost a year after the company—now known as Lakefront Biotherapeutics—abandoned them.
October 15, 2026
·
4 min read
·
Annalee Armstrong
China
China’s licensing deals soar as US biotechs enjoy a bumper M&A year
China may be taking the majority of licensing deals this year but those transactions don’t tell the whole story, according to Locust Walk, which points to the spike in M&A among U.S. biotechs as leveling the playing field.
October 21, 2026
·
3 min read
·
Annalee Armstrong
IPO
Biotech IPOs raise $7.5B as sector’s performance rally flattens
While biopharma financing exit activity has remained strong through the third quarter, public-market performance for the same period was muted, with most of the yearly gains for the U.S. biotech-specific index largely driven by the first half of 2026.
October 26, 2026
·
1 min read
·
Gabrielle Masson
Policy
China poses increasing security risk as US biotech innovation edge erodes
The U.S. is scrambling to compete with a strategically positioned China on the biotech stage as the Asian country surpasses America in biomedical research and clinical trials. So far, China is winning.
August 31, 2026
·
10 min read
·
Michael Gibney
CHINA
Webinar: The China question: Can US biotechs lead as investment heads east?
In this webinar, BioSpace will gathered experts to discuss China’s impact on the future of biotech and how both U.S. and Chinese companies can thrive—and maybe even collaborate.
October 15, 2026
·
1 min read
·
Annalee Armstrong
China
Without US action on China’s innovation blitz, biotech leaders see a Rust Belt future
Policy uncertainty is hampering the growth of U.S. biotech as China rises thanks to carefully planned investment in the industry, experts said during a
BioSpace
webinar.
November 11, 2026
·
5 min read
·
Annalee Armstrong
China
US explores China biotech restrictions, exempts licensing deals
A new proposal from the U.S. government seeking to address investment in Chinese biotech as a matter of national security drew cautious statements from across the industry, with leaders vowing to ensure innovation isn’t stifled.
October 23, 2026
·
3 min read
·
Annalee Armstrong
Opinion
Emerging biotech hubs step up as innovation economics evolve
How India and other emerging hubs for drug development can be key to reshaping medical costs globally.
November 16, 2026
·
5 min read
·
Jogin Desai
1 of 67,534
Next